期刊文献+

子宫内膜异位症发病机制及其治疗分类研究 被引量:10

Classification Study on Pathogenesis and Treatment of Endometriosis
下载PDF
导出
摘要 子宫内膜异位症(endometriosis,EMs)是指内膜细胞种植在不正常的位置而形成的一种女性常见妇科疾病,它与痛经、性交痛、非循环骨盆疼痛及生育能力低下等有关。子宫内膜异位症的发病机制非常复杂,涉及到细胞黏附能力增强、细胞外基质的降解、血管生成、增殖、异常细胞凋亡,干扰细胞通讯,免疫系统的破坏,失去分化能力和其他病理生理过程。本论文主要探讨了子宫内膜异位症的发病机制及其分类,并对当前常用的临床治疗方法予以综述。 Endometriosis ( EMs ) is a common gynecological disease which is formed when the endometrial cells are planted in the abnormal, it is associated with dysmenorrhea, intercourse pain, non-cyclic pelvic pain and low fertility and so on. The pathogenesis of endometriosis is complex, involving increased cell adhesion, extraeellular matrix degradation, angiogenesis, proliferation, abnormal cell apoptosis, interference cell communication, the destruction of the immune system, loss of differentiation and other path physiological processes. This paper mainly discusses the pathogenesis of endometriosis and its classification, and the current commonly used clinical treatment methods are reviewed.
作者 刘瑞景 蔡海燕 LIU Rui-jing CAI Hai-yan(Dalang Hospital of Dongguan , Dongguan 523770, Chin)
出处 《中国医学创新》 CAS 2017年第6期145-148,共4页 Medical Innovation of China
关键词 子宫内膜异位症 发病机制 疾病分类 妇科疾病 Endometriosis Pathogenesis Disease classification Gynecological diseases
  • 相关文献

参考文献12

二级参考文献101

  • 1于雯.超声诊断子宫内膜异位症的临床分析[J].辽宁中医药大学学报,2009,11(3):134-135. 被引量:3
  • 2张瑞华.腹腔镜手术联合药物治疗子宫内膜异位症的临床观察及护理[J].黑龙江医学,2013,37(11):1117-1117. 被引量:5
  • 3马彩虹,陈贵安,韩劲松,王晓晔.骨桥蛋白和整合素在子宫内膜异位症中的表达[J].中国生育健康杂志,2006,17(6):355-358. 被引量:8
  • 4Sakamoto Y, Harada T, Horie S, et al.Tumor necrosis factoralpha induced interleukin-8( IL-8 ) expression in en dometriotics troma cells,probably through nuclear factorkappa B active on gonadotropin-releasing ghormonea gonist treatment educed IL-8 expression[J].J Clin Endocrinol Metab, 2003,88( 2 ) : 730-735.
  • 5Clayton R D,Duffy S R, Wilkinson N, et al. Antiproliferative effect of mycobateria, IFN-gamma and TNF-alpha on pri mary cultures derived from endometrial stroma possible relevance to endometriosis [J]. Am J Reprod Immunol, 2004,51 ( 1 ) : 63-70.
  • 6D'Antonio M,Martelli F,Peano S,et al. Ability of reeombi nant human TNF binding protein-1 ( r-hTBP-I ) to inhibit the development of experimentally-induced endometriosis in rats[J]. J Reprod Immunol,2000,48(2) : 81 - 98.
  • 7Yamauchi N, Harada T, Taniguchi F, et al. Tumor necrosis factoralpha induced the release of interleukin- 6 from endometriotic stromal cells by the nuclear factor - kappaB and mitogen- aetivated protein kinase pathways[J]. Fertil teril, 2004,82[ Suppl 3 ] : 1023-1028.
  • 8Sakamoto Y, Harada T, Horie S, et al. Tumor necrosis factor-alphaindueed interleukin- 8 (IL- 8) expression in endometriotie stromal cells, probably through nuclear factor - kappa B activation: gonadotropin- releasing hormone agonist treatment reduced IL - 8 expression[J]. J Clin Endocrinol Metab, 2003,88 (2) : 730- 735.
  • 9Wieser F, Vigne J L, Ryan I, et al. Sulindac suppresses nuclear factor -kappaB activation and RANTES gene and protein expression in endometrial stromal cells fromwomen with endometriosis[J]. J Clin Endocrinol Metab,2005,90 ( 12 ) : 6441 - 6447.
  • 10Sillern M,Parviz M,Woitge HW,et a1.Add-back medrogestone doesnot prevent bone loss in premenopausal women treated with goserelin[J].Exp Clin Endocrinol Diabetes,2009,107(6):379-385.

共引文献123

同被引文献96

引证文献10

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部